Oncologists describe a typical presentation of endometrial carcinoma and debate the implications of radiation treatment.

An overview of biomarker testing in endometrial carcinoma.

Physician-researchers discuss the risk of recurrence in endometrial carcinoma and the available treatment options after relapse.

Drs Bradley Monk and David O’Malley explain dose reduction in endometrial carcinoma treatment based on clinical trial data.

Experts explain the need for germline testing and genetic counseling for patients with endometrial carcinoma as demonstrated by a patient case.

A review of data from several clinical trials on the use of I/O + chemotherapy as treatment for endometrial carcinoma.

Dr David O’Malley explains when to add and remove trastuzumab during endometrial carcinoma therapy.

Oncologists debate the proper treatment of a patient with a grade 2 endometrial carcinoma tumor.

A discussion on the best way to sequence therapies for patients with MSI-high and MMR-proficient endometrial carcinoma.